AMZN
Amazon.com, Inc.
AMZN has the edge over NDLS overall, supported by lower modeled downside and stronger valuation.
NDLS
Noodles & Company
NDLS trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
NDLS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
NDLS's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
NDLS PE Valuation
NDLS has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
NDLS Forward outlook
There aren't enough analyst estimates for NDLS to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over NDLS on earnings quality, reporting a profit while its opponent remains loss making.
NDLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.97 | +$3.55 |
| Q1 2026 | -$6.34 | +$0.54 |
| Q4 2025 | -$7.36 | -$0.96 |
| Q3 2025 | -$7.92 | -$2.16 |
| Q2 2025 | -$7.52 | -$3.12 |
| Q1 2025 | -$6.88 | -$4.64 |
| Q4 2024 | -$6.40 | -$4.72 |
| Q3 2024 | -$5.76 | -$5.28 |
NDLS lost $3.97 per share over the past year, a smaller loss than the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over NDLS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over NDLS on profitability, with a higher operating margin.
NDLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $127M | +0.5% |
| Q1 2026 | $123.8M | 0% |
| Q4 2025 | $122.8M | +0.8% |
| Q3 2025 | $122.1M | -0.5% |
| Q2 2025 | $126.4M | -0.7% |
| Q1 2025 | $123.8M | +2% |
| Q4 2024 | $121.8M | -2% |
| Q3 2024 | $122.8M | -4% |
NDLS's revenue grew through 2021 and has held roughly level since: $127M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | +11 points |
| Q1 2026 | -0.7% | +4.5 points |
| Q4 2025 | -3.3% | +2.7 points |
| Q3 2025 | -5.2% | -1.3 points |
| Q2 2025 | -12% | -2.7 points |
| Q1 2025 | -5.2% | -1.8 points |
| Q4 2024 | -6% | -2.4 points |
| Q3 2024 | -3.9% | -5.5 points |
NDLS's operating margin was −1.2% last quarter, up 10 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
NDLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.8M | +$6M |
| Q1 2026 | $3.9M | +253% |
| Q4 2025 | -$3.4M | +$10.4M |
| Q3 2025 | $1.4M | +$2.8M |
| Q2 2025 | -$4.3M | +$205K |
| Q1 2025 | $1.1M | +$2.8M |
| Q4 2024 | -$13.8M | +$1.4M |
| Q3 2024 | -$1.3M | -132% |
NDLS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over NDLS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
NDLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +65.9K shares |
| 1 year | +2.7% | +157K shares |
| 3 years | +2.3% | +132K shares |
| 5 years | +2.5% | +147K shares |
| Available history | +5.6% | +315K shares |
NDLS has 6M diluted shares, up 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2023 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over NDLS on leverage, with a lower net debt burden relative to earnings.
NDLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 8.7x | High |
| Q4 2024 | 77.3x | High |
| Q3 2024 | 18.9x | High |
| Q2 2024 | 7.8x | High |
| Q1 2024 | 3.8x | Elevated |
| Q4 2023 | 3.6x | Elevated |
| Q3 2023 | 2.3x | Moderate |
| Q2 2023 | 2.4x | Moderate |
NDLS's net debt is about 8.7 years of its operating earnings (EBITDA), up from 3.8 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
NDLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 38.4 | Neutral |
NDLS's weekly RSI is 52 (neutral) and its Stochastic is 38 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
NDLS PE vs Consumer Cyclical Sector
| Metric | NDLS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
NDLS has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over NDLS on trend strength, trading above more of its moving averages.
NDLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.6 | 1% above |
| 20 week MA | $14.4 | 4.6% below |
| 50 week MA | $10.9 | 26% above |
| 100 week MA | $9.01 | 53% above |
| 200 week MA | $15.4 | 11% below |
NDLS's trend is mixed: it's above three of its five weekly moving averages, and 11% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
NDLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.4 | $63.3 | +43% |
| 2021 | $63.3 | $75.8 | +20% |
| 2022 | $75.8 | $41.3 | -46% |
| 2023 | $41.3 | $25.2 | -39% |
| 2024 | $25.2 | $4.89 | -81% |
| 2025 | $4.89 | $5.66 | +16% |
| 2026 YTD | $5.66 | $13.8 | +143% |
NDLS has the edge over AMZN on returns for 2026, with the stronger performance.